Alderaan Biotechnology

About:

Alderaan is a biotechnology company.

Website: https://alderaan-biotechnology.com/

Top Investors: Medicxi, AdBio partners

Description:

Alderaan Biotechnology is a Biotechnology company develops antibodies targeting new and original targets in immuno-oncology, expressed by NK cells in particular.

Total Funding Amount:

20M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2017-01-01

Founders:

Armand Bensussan, Arnaud Foussat, Daniel Olive

Number of Employees:

1-10

Last Funding Date:

2020-01-09

IPO Status:

Private

Industries: